ClinConnect ClinConnect Logo
Search / Trial NCT05931692

Virtual Reality and Fear of Falling in Parkinson's Disease

Launched by AHRAM CANADIAN UNIVERSITY · Jul 1, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to better understand and measure the fear of falling in people with Parkinson's disease using virtual reality (VR). Falls are common in those with Parkinson's, and the fear of falling can make their balance and movement even worse. This study aims to create a new way to assess this fear more objectively by observing how participants move in both real and virtual environments. By using VR, researchers hope to see how the fear of falling affects different aspects of movement, like balance and muscle response.

To be eligible for the trial, participants need to be at least 40 years old and have a diagnosis of Parkinson's disease. They should be able to walk independently and experience a significant fear of falling. During the study, participants will complete questionnaires and movement tasks in VR, allowing researchers to gather data on their balance and stability. The findings could help improve how fear of falling is assessed and managed in individuals with Parkinson's, ultimately leading to better support and care for those affected.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • People ≥ 40 years old.
  • Participants diagnosed with Parkinson's disease by a neurologist, regardless the type.
  • Modified Hoehn and Yahr stages I to III.
  • Able to follow instructions and understand questions.
  • Able to walk independently and without walking aids.
  • People who experience excessive fear of falling and fear of movement.
  • Able to communicate verbally.
  • Stable use of Parkinson's Disease or other comorbidities medications.
  • Exclusion Criteria:
  • Impaired vision and hearing.
  • Unstable medical condition.
  • Co-existing neurological or orthopedic conditions that may limit mobility and affect participation.
  • Dizziness, vertigo, headache, and motion-sickness.
  • Cognition impairments.
  • Pregnancy.

About Ahram Canadian University

Ahram Canadian University is a distinguished educational institution committed to advancing research and innovation in the field of healthcare. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to conduct rigorous research studies that contribute to the understanding of medical treatments and interventions. By fostering collaboration among researchers, healthcare professionals, and industry partners, Ahram Canadian University aims to enhance patient outcomes and drive the development of evidence-based practices in medicine. Through its commitment to ethical standards and scientific integrity, the university plays a pivotal role in shaping the future of healthcare research.

Locations

Al ḩayy Ath Thāmin, Giza, Egypt

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Yasmine S Gomaa, Ph.d

Principal Investigator

Kafrelsheikh University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported